MPO and acute coronary syndrome: Myeloperoxidase has been proposed as a useful risk marker and diagnostic tool in acute coronary syndromes and patients admitted to an emergency room for chest pain [7], as increased serum levels of MPO are predictors of major adverse cardiac events [8].